Is this you?
Request access for New Hope Clinical Research with your @newhopeclinicalresearch.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.
New Hope Clinical Research
Unclaimed profileIndependent Site · Charlotte, North Carolina · ~1 sites
Intera lens
ICP 6Lift (cardio sample) 0.05Recruit soph 0.57
Quality Scorecard (1–100)
Overall90Recruit81Ops91Sponsor94Ther96
Performance (observed)
Historical trials
773
Completed
411
Terminated/Withdrawn
96
Completion rate
81%
Active now
245
Phase 2
271
Phase 3
459
Realized enrollment
841,945
First study year
1994
Years active
32
Match confidence
high
Enrollment velocity (inf)
26,311
Therapeutic
Areas
Psychiatry, Neurology, Neuroscience, CNS, Depression, Schizophrenia, Alzheimer's Disease, Bipolar Disorder, PTSD
Breadth (conditions)
1,540
Languages
English
States
North Carolina
Recruitment (web observed)
Trial Finder
Yes
Patient database
Y
Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Phase I-IV trial descriptions; active study listings
Capability notes
High - Phase I-IV specialized facility with FDA audit clearance (no findings)
Relationships
Sponsors
National Cancer Institute (NCI); SWOG Cancer Research Network; Merck Sharp & Dohme LLC; Pfizer; Children's Oncology Group; Alliance for Clinical Trials in Oncology
CROs
Acrotech Biopharma Inc.; IQVIA Pty Ltd; Laboratorios Liconsa; MacroGenics; Medpace, Inc.; PPD Development, LP
Partnerships
Duke fellowship program mentioned (founder)
Owner / parent
Private, Founded 2009/2012
Expansion
Single Charlotte, NC location
Capacity & people
Investigators
—
Coordinators
—
CEO
Tammy Rader, MBA (Founder & CEO)
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Unknown
Tech & DCT
Builds tech
Unknown
Tech stack
Unknown
Recruiting visible
Y
Notes
Phase I-IV facility with founder Tammy Rader (22+ years industry experience). FDA routine inspection with zero findings (rare: only 20% of FDA inspections result in no significant deficiencies). CNS-focused specialty. ctgov_note: 7 recruiting trials across 1 location(s), states: North Carolina
Recommendation features (sample indication)
Ind fit 0.12Liftability 0.05Overall90
FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.